FDA inspection
Novocol Pharmaceutical of Canada, Inc.: FDA inspection ending Jan 30, 2020
FDA inspection 1117454 · No Action Indicated (NAI) · Cambridge
Key facts
| Inspection ID | 1117454 |
|---|---|
| Firm | Novocol Pharmaceutical of Canada, Inc. |
| FEI number | 3002807757 |
| Address | 25 Wolseley Crt |
| City | Cambridge |
| Country | Canada |
| Fiscal year | 2020 |
| Inspection end date | Jan 30, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data